ATE542810T1 - Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton - Google Patents

Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton

Info

Publication number
ATE542810T1
ATE542810T1 AT07857390T AT07857390T ATE542810T1 AT E542810 T1 ATE542810 T1 AT E542810T1 AT 07857390 T AT07857390 T AT 07857390T AT 07857390 T AT07857390 T AT 07857390T AT E542810 T1 ATE542810 T1 AT E542810T1
Authority
AT
Austria
Prior art keywords
methyl
ribono
lactone
acyl
omikron
Prior art date
Application number
AT07857390T
Other languages
English (en)
Inventor
Miall Cedilote
Thomas P Cleary
Hans Iding
Pingsheng Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE542810T1 publication Critical patent/ATE542810T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT07857390T 2006-12-18 2007-12-11 Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton ATE542810T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87561706P 2006-12-18 2006-12-18
PCT/EP2007/063703 WO2008074693A2 (en) 2006-12-18 2007-12-11 Process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone

Publications (1)

Publication Number Publication Date
ATE542810T1 true ATE542810T1 (de) 2012-02-15

Family

ID=39433788

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07857390T ATE542810T1 (de) 2006-12-18 2007-12-11 Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton

Country Status (13)

Country Link
US (1) US7838693B2 (de)
EP (1) EP2094679B1 (de)
JP (1) JP5148627B2 (de)
KR (1) KR101118413B1 (de)
CN (1) CN101573349B (de)
AT (1) ATE542810T1 (de)
AU (1) AU2007336365B2 (de)
BR (1) BRPI0720835A2 (de)
CA (1) CA2671856C (de)
ES (1) ES2379696T3 (de)
IL (1) IL198801A (de)
MX (1) MX2009006156A (de)
WO (1) WO2008074693A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103724301A (zh) 2012-10-10 2014-04-16 上海特化医药科技有限公司 (2r)-2-脱氧-2,2-二取代-1,4-核糖内酯及其制备方法和用途
CN104918924B (zh) * 2013-01-14 2018-05-11 吉利德制药有限责任公司 制备氟代内酯衍生物的方法
AR094466A1 (es) * 2013-01-14 2015-08-05 Hoffmann La Roche Proceso para la obtención de un derivado de fluorlactona
JP6394588B2 (ja) * 2013-02-28 2018-09-26 セントラル硝子株式会社 (2R)−2−フルオロ−2−C−メチル−D−リボノ−γ−ラクトンの製造方法
JP6476591B2 (ja) * 2013-06-05 2019-03-06 セントラル硝子株式会社 (2R)−2−フルオロ−2−C−メチル−D−リボノ−γ−ラクトン類の製造方法
CN105085445B (zh) * 2015-08-11 2016-09-07 海门慧聚药业有限公司 索非布韦中间体的制备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050025916A1 (en) * 2000-11-30 2005-02-03 Hideki Nakanishi Transfer sheet
WO2003076424A1 (en) * 2002-03-08 2003-09-18 Eisai Co. Ltd. Macrocyclic compounds useful as pharmaceuticals
CN100503628C (zh) * 2003-05-30 2009-06-24 法莫赛特股份有限公司 修饰的氟化核苷类似物
CA2574651C (en) 2004-07-21 2013-05-21 Pharmasset, Inc. Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives
BRPI0515279A (pt) * 2004-09-14 2008-07-15 Pharmasset Inc preparação de ribofuranosil pirimidinas e purinas 2'fluoro-2'-alquil- substituìdas ou outras opcionalmente substituìdas e seus derivados

Also Published As

Publication number Publication date
CA2671856A1 (en) 2008-06-26
IL198801A0 (en) 2010-02-17
US7838693B2 (en) 2010-11-23
US20080145901A1 (en) 2008-06-19
IL198801A (en) 2013-08-29
JP2010513377A (ja) 2010-04-30
BRPI0720835A2 (pt) 2015-09-29
ES2379696T3 (es) 2012-04-30
CA2671856C (en) 2015-02-10
KR20090080562A (ko) 2009-07-24
MX2009006156A (es) 2009-06-19
CN101573349A (zh) 2009-11-04
WO2008074693A2 (en) 2008-06-26
JP5148627B2 (ja) 2013-02-20
EP2094679B1 (de) 2012-01-25
WO2008074693A3 (en) 2008-10-30
AU2007336365B2 (en) 2013-03-07
CN101573349B (zh) 2013-07-10
EP2094679A2 (de) 2009-09-02
KR101118413B1 (ko) 2012-03-07
AU2007336365A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
ATE486844T1 (de) Verfahren zur herstellung von adipodinitril durch hydrocyanierung von 1,3-butadien
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
ATE478084T1 (de) Verfahren zur herstellung von 4'- azidocytidinderivaten
ATE444977T1 (de) Verfahren zur herstellung von aba- triblockcopolymeren auf (meth)acrylatbasis
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
ATE469908T1 (de) Verfahren zur herstellung von pimecrolimus
ATE414077T1 (de) Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivaten
ATE542810T1 (de) Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton
DE60311990D1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE527012T1 (de) Verfahren zur herstellung von medizinprodukten mit einer opferstruktur
CY1120487T1 (el) Νεα μεθοδος για τη θεραπεια λοιμωξεων απο ελικοβακτηριδιο του πυλωρου (η. pylori)
ATE376997T1 (de) Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
ATE344273T1 (de) Verfahren zur herstellung von 21-hydroxy-6,19- oxidoprogesteron (21oh-6op)
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
ATE397611T1 (de) Verfahren zur herstellung von olanzapin
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t
DE60335766D1 (de) Verfahren zur Herstellung von m-Xylylendiamin
ATE423764T1 (de) Verfahren zur herstellung von hydrazon-derivaten
ATE341558T1 (de) Verfahren zur herstellung von topiramate
DE602006013688D1 (de) Neues verfahren zur herstellung von thoc
ATE380183T1 (de) Verfahren zur herstellung von phenyltetrazolderivaten
DE502004007177D1 (de) VERFAHREN ZUR HERSTELLUNG VON (3-OXO-2,3-DIHYDRO-1H-ISOINDOL-1-Yl)-ACETYLGUANIDIN-DERIVATEN